cas 499770-71-7|| where to buy 5-(BROMOMETHYL)-1-METHYL-1H-IMIDAZOLE

Produktname:5-(BROMOMETHYL)-1-METHYL-1H-IMIDAZOLE

IUPAC Name:5-(bromomethyl)-1-methyl-1H-imidazole

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM595453-50mg	in stock	ŵȐũư
CM595453-100mg	in stock	ŵȡũũ
CM595453-250mg	in stock	ŵŵũũ
CM595453-500mg	in stock	ŵǶũŵ
CM595453-1g	in stock	ŵũǶư

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 499770-71-7 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:499770-71-7; Molekulare Formel:C5H7BrN2; Schmelzpunkt:-; SMILES-Code:CN1C=NC=C1CBr; Dichte:

: Katalognummer:CM595453; Molekulargewicht:175.03; Siedepunkt:; Mdl-Nr.:MFCD05664672; Lagerung:

: Imidazoles; Imidazole is an important five-membered nitrogen-containing heterocyclic compound. Among the numerous heterocyclic compounds, imidazole and its derivatives are regarded as a unique and multifaceted scaffold material due to their diverse applications in industrial, organic and pharmaceutical chemistry. Imidazoles interact in different ways with many therapeutic targets, enzymes and receptors in biological systems and thus exhibit a wide range of biological activities. In particular, several imidazoles can be used as clinical drugs to treat various types of cancer with high therapeutic efficacy. Furthermore, imidazoles are one of the most critical segments in the field of anti-covid-19 virus drug discovery due to their ability to interact with active targets in living systems.; Imidazole Manufacturer; As a professional imidazole manufacturer, we can guarantee product quality and delivery time.our company has been committed to supply personalized product solutions to customers,pls consult us.